ARCHIVES

BMS Settles Charges Of Obstructing Generics

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

Clinical Research; Duke Received Several Warnings from OPRR, Letters Indicate

May 14, 1999

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994

Nine More state To Pay For Cancer Treatment Of CDC-Screened Women.

September 7, 2001

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003

Unique Molecular Profile For Lung Cancer Described

March 31, 2006